Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension. - Suppr | 超能文献

Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.

作者信息

Hamaguchi Yasuhito, Fujimoto Manabu, Hasegawa Minoru, Matsushita Takashi, Takehara Kazuhiko

出版信息

J Dermatol Sci. 2009 Jul;55(1):66-7. doi: 10.1016/j.jdermsci.2009.02.013. Epub 2009 Apr 1.

DOI:10.1016/j.jdermsci.2009.02.013

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.

J Dermatol Sci. 2009 Jul;55(1):66-7. doi: 10.1016/j.jdermsci.2009.02.013. Epub 2009 Apr 1.

2

Bosentan therapy for pulmonary arterial hypertension.波生坦治疗肺动脉高压

N Engl J Med. 2002 Mar 21;346(12):896-903. doi: 10.1056/NEJMoa012212.

3

Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.内皮素受体拮抗剂波生坦改善系统性硬皮病患者的皮肤硬化。

Australas J Dermatol. 2012 May;53(2):e32-3. doi: 10.1111/j.1440-0960.2010.00719.x. Epub 2010 Nov 29.

4

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.硬皮病相关肺动脉高压管理的新时代：内皮素受体拮抗剂治疗

Ann Rheum Dis. 2004 Sep;63(9):1009-14. doi: 10.1136/ard.2003.017673.

5

Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.用于治疗系统性硬化症相关肺动脉高压的内皮素-1受体拮抗剂

Curr Rheumatol Rep. 2003 Apr;5(2):145-6. doi: 10.1007/s11926-003-0042-4.

6

Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.波生坦用于治疗与系统性硬化症相关的间质性肺疾病所致的重度肺动脉高压。

Eur J Clin Invest. 2006 Sep;36 Suppl 3:44-8. doi: 10.1111/j.1365-2362.2006.01695.x.

7

N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment.波生坦治疗下系统性硬化症相关肺动脉高压患者的N末端前脑钠肽

Rheumatol Int. 2009 Jan;29(3):347-8. doi: 10.1007/s00296-008-0667-8. Epub 2008 Aug 9.

8

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.系统性硬化症中的指端溃疡：通过口服内皮素受体拮抗剂波生坦治疗进行预防

Arthritis Rheum. 2004 Dec;50(12):3985-93. doi: 10.1002/art.20676.

9

Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.继发性肺动脉高压：采用内皮素受体阻滞剂治疗。

Tex Heart Inst J. 2005;32(3):405-10.

10

The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.波生坦对系统性硬化症所致肺动脉高压患者基质金属蛋白酶-9水平的影响。

Curr Med Res Opin. 2005 Mar;21(3):327-32. doi: 10.1185/030079905X30680.

引用本文的文献

1

Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension.调节性T细胞衍生的白细胞介素35通过信号转导和转录激活因子1减轻肺动脉高压中的内皮细胞增殖。

Ann Transl Med. 2021 Jun;9(11):926. doi: 10.21037/atm-21-1952.

2

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.波生坦：用于治疗系统性硬化症相关指端溃疡的综述

Drugs. 2009 Oct 1;69(14):2005-24. doi: 10.2165/10489160-000000000-00000.